對呀 我也這麼覺得

Ceftolozane is a potent PBP3 inhibitor and has a higher affinity for PBP1b compared with other β-lactam agents; for these reasons, ceftolozane/tazobactam differs from other cephalosporins due to its increased activity against some AmpC β-lactamases, especially P aeruginosa.

https://www.ncbi.nlm.nih...
mixed findings across studies.